Related references
Note: Only part of the references are listed.Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems
Guillermo Moreno-Alcantar et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)
Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Quratulain Babar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani et al.
DRUG RESISTANCE UPDATES (2022)
Inhibition of Cathepsin B by Ferrocenyl Indenes Highlights a new Pharmacological Facet of Ferrocifens
Juan Sanz Garcia et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2022)
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness
Tania Gamberi et al.
MEDICINAL RESEARCH REVIEWS (2022)
Thioredoxin Reductase Inhibition for Cancer Therapy
Radosveta Gencheva et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
Heteroleptic Gold(I)-bisNHC complex with excellent activity in vitro, ex vivo and in vivo against endometrial cancer
Qimeng Xiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)
Giovanni Chiappetta et al.
REDOX BIOLOGY (2022)
Fast Hydrolysis and Strongly Basic Water Adducts Lead to Potent Os(II) Half-Sandwich Anticancer Complexes
Sonia Infante-Tadeo et al.
INORGANIC CHEMISTRY (2022)
Au4 cluster inhibits human thioredoxin reductase activity via specifically binding of Au to Cys189
Zhongying Du et al.
NANO TODAY (2022)
Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases
Radosveta Gencheva et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran et al.
FRONTIERS IN ONCOLOGY (2022)
Current Developments of N-Heterocyclic Carbene Au(I)/Au(III) Complexes toward Cancer Treatment
Alexia Tialiou et al.
BIOMEDICINES (2022)
Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases
Yunlong Lu et al.
CHEMICAL SOCIETY REVIEWS (2022)
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Eric F. Pettersen et al.
PROTEIN SCIENCE (2021)
[(C C)Au(N N)]+ Complexes as a New Family of Anticancer Candidates: Synthesis, Characterization and Exploration of the Antiproliferative Properties
Silva Khodjoyan et al.
CHEMISTRY-A EUROPEAN JOURNAL (2021)
Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer
Marina Delgobo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides. Their contribution to biology
Anne Vessieres et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Making Aggregation-Induced Emission Luminogen More Valuable by Gold: Enhancing Anticancer Efficacy by Suppressing Thioredoxin Reductase Activity
Hang Zou et al.
ACS NANO (2021)
Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
Pierre Sabatier et al.
REDOX BIOLOGY (2021)
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
Jerneja Kladnik et al.
CANCERS (2021)
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes
Anne Vessieres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The gold complex auranofin: new perspectives for cancer therapy
Farah H. Abdalbari et al.
DISCOVER ONCOLOGY (2021)
Multifunctional AuI-based AIEgens: Manipulating Molecular Structures and Boosting Specific Cancer Cell Imaging and Theranostics
Zhang Jing et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Chemistry, structure, and biological roles of Au-NHC complexes as TrxR inhibitors
Merve Goksin Karaaslan et al.
BIOORGANIC CHEMISTRY (2020)
A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti-Ovarian-Cancer Agent by Inhibiting TrxR and Activating ROS-Mediated ERS
Mianli Bian et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
The Thioredoxin System: A Promising Target for Cancer Drug Development
Hiba Ghareeb et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer
Ke-Tao Jin et al.
RNA BIOLOGY (2020)
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle et al.
DRUG RESISTANCE UPDATES (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin
Amir Ata Saei et al.
REDOX BIOLOGY (2020)
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties
Ida Landini et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods
Lara Massai et al.
FRONTIERS IN CHEMISTRY (2020)
Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
Xiaonan Zhang et al.
BIOCHIMIE (2019)
Small Structural Differences between Two Ferrocenyl Diphenols Determine Large Discrepancies of Reactivity and Biological Effects
Federica Tonolo et al.
CHEMMEDCHEM (2019)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny et al.
CHEMICAL REVIEWS (2019)
A gold(I) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs
Claudia Schmidt et al.
METALLOMICS (2019)
Gold(III) Complexes for Antitumor Applications: An Overview
Benoit Bertrand et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation
Chen Zhang et al.
CHEMMEDCHEM (2018)
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
Alberta Bergamo et al.
COORDINATION CHEMISTRY REVIEWS (2018)
Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors
Valeria Scalcon et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Modulation of thiol-dependent redox system by metal ions via thioredoxin and glutaredoxin systems
Yanfang Ouyang et al.
METALLOMICS (2018)
Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?
Chien Ing Yeo et al.
MOLECULES (2018)
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
William C. Stafford et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Pharmacomodulation on Gold-NHC complexes for anticancer applications - is lipophilicity the key point?
Chen Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
Targeting the Thioredoxin System for Cancer Therapy
Junmin Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(I) N-heterocyclic carbene complexes
R. McCall et al.
CHEMICAL SCIENCE (2017)
TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
Binsheng Fu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Exploring the theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes
Sophie Juergens et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands
Simon J. Allison et al.
CANCER LETTERS (2017)
Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors
Yizhe Cheng et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation
Yong Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
The length of the bridging chain in ansa-metallocenes influences their antiproliferative activity against triple negative breast cancer cells (TNBC)
Matthieu Beauperin et al.
DALTON TRANSACTIONS (2016)
Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms
Le Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues
Xiu Chen et al.
GENE (2016)
Mass Spectrometry Uncovers Molecular Reactivities of Coordination and Organometallic Gold(III) Drug Candidates in Competitive Experiments That Correlate with Their Biological Effects
Samuel M. Meier et al.
INORGANIC CHEMISTRY (2016)
Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis
Erik Schoenmakers et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Enzymatic oxidation of ansa-ferrocifen leads to strong and selective thioredoxin reductase inhibition in vitro
Valeria Scalcon et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Osmocenyl-tamoxifen derivatives target the thioredoxin system leading to a redox imbalance in Jurkat cells
Valeria Scalcon et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro
Yiu Fung Mui et al.
ORGANOMETALLICS (2016)
Update on Selenoprotein Biosynthesis
Anne-Laure Bulteau et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Ferrocifen type anti cancer drugs
Gerard Jaouen et al.
CHEMICAL SOCIETY REVIEWS (2015)
Synthesis, Characterization, and Biological Properties of Osmium-Based Tamoxifen Derivatives - Comparison with Their Homologues in the Iron and Ruthenium Series
Hui Zhi Shirley Lee et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2015)
Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis
Rianne M. Lord et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
pH-Sensitive Polymeric Nanoparticles with Gold(I) Compound Payloads Synergistically Induce Cancer Cell Death through Modulation of Autophagy
Yao-Xin Lin et al.
MOLECULAR PHARMACEUTICS (2015)
A novel aminotriazole-based NHC complex for the design of gold(I) anti-cancer agents: synthesis and biological evaluation
T. V. Serebryanskaya et al.
MEDCHEMCOMM (2015)
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder et al.
DRUGS IN R&D (2015)
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Qiong Wu et al.
CANCER LETTERS (2014)
Anticancer Profile of a Series of Gold(III) (2-phenyl)pyridine Complexes
Riccardo Rubbiani et al.
CHEMMEDCHEM (2014)
Thioredoxin Reductase and its Inhibitors
Fulvio Saccoccia et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2014)
Conventional versus stealth lipid nanoparticles: Formulation and in vivo fate prediction through FRET monitoring
A. -L. Laine et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation
Alessandro Pratesi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells
Anna Citta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and Molecular Recognition Studies on Small-Molecule Inhibitors for Thioredoxin Reductase
Di Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
SELENOPROTEINS: MOLECULAR PATHWAYS AND PHYSIOLOGICAL ROLES
Vyacheslav M. Labunskyy et al.
PHYSIOLOGICAL REVIEWS (2014)
The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer
Anne-Laure Laine et al.
BIOMATERIALS (2013)
Exploration of the medical periodic table: towards new targets
Nicolas P. E. Barry et al.
CHEMICAL COMMUNICATIONS (2013)
Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules
Luciano Oehninger et al.
DALTON TRANSACTIONS (2013)
N-Heterocyclic carbene metal complexes in medicinal chemistry
Luciano Oehninger et al.
DALTON TRANSACTIONS (2013)
Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes
Valentina Gandin et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights
Anna Citta et al.
METALLOMICS (2013)
A dinuclear cyclometalated gold(III)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo
Raymond Wai-Yin Sun et al.
CHEMICAL SCIENCE (2013)
On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
Andreas Meyer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase
Xiaoxiao Peng et al.
BIOCHEMICAL JOURNAL (2012)
Enhanced cytotoxicity of silver complexes bearing bidentate N-heterocyclic carbene ligands
Diana C. F. Monteiro et al.
DALTON TRANSACTIONS (2012)
Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents
Esther Schuh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The biological activity of auranofin: implications for novel treatment of diseases
J. M. Madeira et al.
INFLAMMOPHARMACOLOGY (2012)
The selenium content of cell culture serum influences redox-regulated gene expression
Therese C. Karlenius et al.
BIOTECHNIQUES (2011)
Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Metal-Based Inhibition of Poly(ADP-ribose) Polymerase - The Guardian Angel of DNA
Filipa Mendes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Organometallic Anticancer Compounds
Gilles Gasser et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Gold compounds as therapeutic agents for human diseases
Susan J. Berners-Price et al.
METALLOMICS (2011)
Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect
Ngoc Trinh Huynh et al.
PHARMACEUTICAL RESEARCH (2011)
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays
Chiara Gabbiani et al.
MEDCHEMCOMM (2011)
Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft
Emilie Allard et al.
PHARMACEUTICAL RESEARCH (2010)
Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer
Cristina Cadenas et al.
BREAST CANCER RESEARCH (2010)
Focus on mammalian thioredoxin reductases - Important selenoproteins with versatile functions
Elias S. J. Arner
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Alberto Bindoli et al.
COORDINATION CHEMISTRY REVIEWS (2009)
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy
Sofl E. Eriksson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Crystal Structure and Catalysis of the Selenoprotein Thioredoxin Reductase 1
Qing Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Selenoproteins
Jun Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1
Yan-Chung Lo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas
Emilie Allard et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium (II)-Arene Compounds
Angela Casini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Mitochondria-targeted chemotherapeutics:: The rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols
James L. Hickey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: Implications for anticancer therapeutics targeted to mitochondria
Oliver Rackham et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis
Karin Fritz-Wolf et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductase
Masashi Takizawa et al.
TOXICOLOGY IN VITRO (2007)
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
Christine Marzano et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea
Jing Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
On the potential of thioredoxin reductase inhibitors for cancer therapy
Sabine Urig et al.
SEMINARS IN CANCER BIOLOGY (2006)
Selenoprotein synthesis: UGA does not end the story
C. Allmang et al.
BIOCHIMIE (2006)
Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity
J Lu et al.
CANCER RESEARCH (2006)
Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases
S Urig et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Mechanisms of cytotoxicity of selected organogold(III) compounds
M Coronnello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The thioredoxin system - From science to clinic
S Gromer et al.
MEDICINAL RESEARCH REVIEWS (2004)
Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
MP Rigobello et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents
PJ Barnard et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens:: Evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines
S Top et al.
CHEMISTRY-A EUROPEAN JOURNAL (2003)
Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative
MP Rigobello et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme
T Sandalova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets
D Grossman et al.
CANCER AND METASTASIS REVIEWS (2001)
Share Paper
